Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $43,102 | 34 | 61.1% |
| Food and Beverage | $19,827 | 1,151 | 28.1% |
| Consulting Fee | $3,765 | 3 | 5.3% |
| Travel and Lodging | $3,363 | 26 | 4.8% |
| Education | $543.40 | 13 | 0.8% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| GENZYME CORPORATION | $52,464 | 130 | $0 (2021) |
| ABBVIE INC. | $1,757 | 112 | $0 (2024) |
| Teva Pharmaceuticals USA, Inc. | $1,456 | 111 | $0 (2024) |
| Biogen, Inc. | $1,361 | 75 | $0 (2023) |
| Novartis Pharmaceuticals Corporation | $1,312 | 85 | $0 (2023) |
| EMD Serono, Inc. | $942.55 | 58 | $0 (2024) |
| Mallinckrodt Enterprises LLC | $849.25 | 74 | $0 (2019) |
| Amgen Inc. | $810.25 | 44 | $0 (2024) |
| UCB, Inc. | $746.55 | 31 | $0 (2024) |
| Alexion Pharmaceuticals, Inc. | $628.51 | 23 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $789.91 | 43 | ABBVIE INC. ($200.25) |
| 2023 | $1,536 | 85 | ABBVIE INC. ($463.26) |
| 2022 | $3,200 | 169 | ABBVIE INC. ($600.12) |
| 2021 | $3,893 | 181 | GENZYME CORPORATION ($775.88) |
| 2020 | $1,474 | 91 | Novartis Pharmaceuticals Corporation ($288.72) |
| 2019 | $3,415 | 193 | Alexion Pharmaceuticals, Inc. ($370.40) |
| 2018 | $31,148 | 225 | GENZYME CORPORATION ($28,912) |
| 2017 | $25,143 | 240 | GENZYME CORPORATION ($22,716) |
All Payment Transactions
1,227 individual payment records from CMS Open Payments — Page 1 of 50
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 09/23/2024 | TG Therapeutics, Inc. | BRIUMVI (Drug) | Food and Beverage | In-kind items and services | $22.64 | General |
| Category: Immunology | ||||||
| 09/18/2024 | ABBVIE INC. | BOTOX (Biological), QULIPTA | Food and Beverage | In-kind items and services | $15.94 | General |
| Category: BOTOX THERAPEUTIC | ||||||
| 09/17/2024 | CATALYST PHARMACEUTICALS, INC. | FYCOMPA (Drug) | Education | Cash or cash equivalent | $16.72 | General |
| Category: NEUROLOGY | ||||||
| 09/17/2024 | ABBVIE INC. | QULIPTA (Drug) | Food and Beverage | In-kind items and services | $11.94 | General |
| Category: NEUROSCIENCE | ||||||
| 08/21/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $18.03 | General |
| Category: PAIN | ||||||
| 08/15/2024 | CATALYST PHARMACEUTICALS, INC. | FYCOMPA (Drug) | Education | Cash or cash equivalent | $16.72 | General |
| Category: NEUROLOGY | ||||||
| 08/14/2024 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $18.26 | General |
| Category: BOTOX THERAPEUTIC | ||||||
| 08/07/2024 | ABBVIE INC. | QULIPTA (Drug) | Food and Beverage | In-kind items and services | $8.94 | General |
| Category: NEUROSCIENCE | ||||||
| 08/05/2024 | Lilly USA, LLC | EMGALITY (Drug), REYVOW | Food and Beverage | In-kind items and services | $21.58 | General |
| Category: Neuroscience | ||||||
| 07/25/2024 | CATALYST PHARMACEUTICALS, INC. | FYCOMPA (Drug) | Education | Cash or cash equivalent | $16.72 | General |
| Category: NEUROLOGY | ||||||
| 07/22/2024 | UCB, Inc. | Nayzilam (Drug) | Food and Beverage | In-kind items and services | $15.73 | General |
| Category: Neurology | ||||||
| 07/17/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $10.43 | General |
| Category: NEUROSCIENCE | ||||||
| 07/16/2024 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $9.67 | General |
| Category: BOTOX THERAPEUTIC | ||||||
| 07/15/2024 | Amgen Inc. | UPLIZNA (Biological) | Food and Beverage | In-kind items and services | $25.87 | General |
| Category: Inflammation/Rare Disease | ||||||
| 07/10/2024 | TG Therapeutics, Inc. | BRIUMVI (Drug) | Food and Beverage | In-kind items and services | $21.10 | General |
| Category: Immunology | ||||||
| 06/26/2024 | ABBVIE INC. | QULIPTA (Drug) | Food and Beverage | In-kind items and services | $10.00 | General |
| Category: NEUROSCIENCE | ||||||
| 06/18/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $21.68 | General |
| Category: PAIN | ||||||
| 06/13/2024 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $26.57 | General |
| Category: BOTOX THERAPEUTIC | ||||||
| 06/12/2024 | ABBVIE INC. | QULIPTA (Drug) | Food and Beverage | In-kind items and services | $14.75 | General |
| Category: NEUROSCIENCE | ||||||
| 06/05/2024 | Lilly USA, LLC | EMGALITY (Drug), REYVOW | Food and Beverage | In-kind items and services | $25.61 | General |
| Category: Neuroscience | ||||||
| 05/28/2024 | ABBVIE INC. | UBRELVY (Drug), BOTOX | Food and Beverage | In-kind items and services | $23.71 | General |
| Category: NEUROSCIENCE | ||||||
| 05/28/2024 | ABBVIE INC. | QULIPTA (Drug) | Food and Beverage | In-kind items and services | $13.32 | General |
| Category: NEUROSCIENCE | ||||||
| 05/09/2024 | Amgen Inc. | UPLIZNA (Biological) | Food and Beverage | In-kind items and services | $19.45 | General |
| Category: Inflammation/Rare Disease | ||||||
| 05/08/2024 | ABBVIE INC. | QULIPTA (Drug) | Food and Beverage | In-kind items and services | $11.33 | General |
| Category: NEUROSCIENCE | ||||||
| 05/06/2024 | CATALYST PHARMACEUTICALS, INC. | FYCOMPA (Drug) | Food and Beverage | Cash or cash equivalent | $13.81 | General |
| Category: NEUROLOGY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 11 | 490 | 16,896 | $363,718 | $146,054 |
| 2022 | 15 | 697 | 33,891 | $676,981 | $218,155 |
| 2021 | 14 | 707 | 24,492 | $720,343 | $207,363 |
| 2020 | 15 | 648 | 20,574 | $605,027 | $161,490 |
All Medicare Procedures & Services
55 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| J0585 | Injection, onabotulinumtoxina, 1 unit | Office | 2023 | 29 | 16,230 | $146,670 | $80,651 | 55.0% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 101 | 144 | $45,157 | $19,252 | 42.6% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 133 | 185 | $38,198 | $15,529 | 40.7% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 95 | 127 | $18,796 | $7,607 | 40.5% |
| 64616 | Injection of chemical for paralysis of nerve muscles on side of neck excluding voice box | Office | 2023 | 17 | 38 | $37,905 | $6,357 | 16.8% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2023 | 30 | 30 | $11,940 | $4,892 | 41.0% |
| 64615 | Injection of chemical for paralysis of facial and neck nerve muscles on both sides of face | Office | 2023 | 11 | 33 | $33,000 | $4,033 | 12.2% |
| 95874 | Needle measurement of electrical activity in muscle with injection of chemical for paralysis of nerve muscle | Office | 2023 | 19 | 41 | $7,462 | $2,682 | 35.9% |
| 95886 | Needle measurement of electrical activity in arm or leg muscles, complete study | Office | 2023 | 23 | 23 | $17,250 | $1,880 | 10.9% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 14 | 14 | $4,116 | $1,723 | 41.9% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 18 | 31 | $3,224 | $1,448 | 44.9% |
| J0585 | Injection, onabotulinumtoxina, 1 unit | Office | 2022 | 41 | 19,000 | $228,000 | $91,835 | 40.3% |
| J7336 | Capsaicin 8% patch, per square centimeter | Office | 2022 | 14 | 13,967 | $74,500 | $35,289 | 47.4% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 211 | 309 | $63,654 | $26,207 | 41.2% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 125 | 181 | $56,653 | $22,735 | 40.1% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 125 | 171 | $25,308 | $11,101 | 43.9% |
| 64616 | Injection of chemical for paralysis of nerve muscles on side of neck excluding voice box | Office | 2022 | 20 | 46 | $45,885 | $7,450 | 16.2% |
| 64615 | Injection of chemical for paralysis of facial and neck nerve muscles on both sides of face | Office | 2022 | 21 | 44 | $117,040 | $5,002 | 4.3% |
| 64640 | Destruction of peripheral nerve or branch | Office | 2022 | 15 | 20 | $13,633 | $4,294 | 31.5% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2022 | 28 | 28 | $11,144 | $3,973 | 35.7% |
| 95874 | Needle measurement of electrical activity in muscle with injection of chemical for paralysis of nerve muscle | Office | 2022 | 22 | 48 | $8,736 | $3,320 | 38.0% |
| 95911 | Nerve conduction, 9-10 studies | Office | 2022 | 11 | 11 | $5,500 | $1,598 | 29.1% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 12 | 12 | $3,528 | $1,514 | 42.9% |
| 95886 | Needle measurement of electrical activity in arm or leg muscles, complete study | Office | 2022 | 16 | 16 | $12,000 | $1,367 | 11.4% |
| 99442 | Telephone medical discussion with physician, 11-20 minutes | Office | 2022 | 25 | 26 | $7,800 | $1,332 | 17.1% |
About Dr. Jill Olson, MD
Dr. Jill Olson, MD is a Neurology healthcare provider based in Fort Collins, Colorado. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/21/2007. The National Provider Identifier (NPI) number assigned to this provider is 1346446903.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Jill Olson, MD has received a total of $70,600 in payments from pharmaceutical and medical device companies, with $789.91 received in 2024. These payments were reported across 1,227 transactions from 73 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($43,102).
As a Medicare-enrolled provider, Olson has provided services to 2,542 Medicare beneficiaries, totaling 95,853 services with total Medicare billing of $733,062. Data is available for 4 years (2020–2023), covering 55 distinct procedure/service records.
Practice Information
- Specialty Neurology
- Location Fort Collins, CO
- Active Since 06/21/2007
- Last Updated 05/05/2020
- Taxonomy Code 2084N0400X
- Entity Type Individual
- NPI Number 1346446903
Products in Payments
- AUBAGIO (Drug) $36,213
- LEMTRADA (Drug) $16,235
- ACTHAR (Biological) $1,324
- BOTOX (Biological) $1,143
- TYSABRI (Biological) $845.43
- Aimovig (Biological) $693.77
- COPAXONE (Drug) $640.92
- NURTEC ODT (Drug) $610.64
- UBRELVY (Drug) $574.31
- KESIMPTA (Drug) $560.86
- TROKENDI XR (Drug) $549.24
- EMGALITY (Drug) $471.57
- Briviact (Drug) $449.64
- APTIOM (Drug) $398.58
- SOLIRIS (Drug) $370.40
- GILENYA (Drug) $339.56
- AJOVY (Drug) $337.96
- ZEPOSIA (Drug) $288.20
- ADUHELM (Biological) $286.20
- QULIPTA (Drug) $283.70
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Neurology Doctors in Fort Collins
Andrew Smith, M.d, M.D
Neurology — Payments: $65,482
Dr. Timothy Allen, Md, MD
Neurology — Payments: $29,868
Dr. Gerald Mcintosh, Md, MD
Neurology — Payments: $1,697
Dr. Brenda George, D.o, D.O
Neurology — Payments: $1,630
Dr. Jessica Williams, M.d, M.D
Neurology — Payments: $1,520
Dr. Brian Kaiser, D.o, D.O
Neurology — Payments: $1,092